Organization · Venture Capital
NYBC Ventures
NYBC Ventures is an early-stage investment fund based in Boston, Massachusetts, focusing on innovations in blood and cellular therapies. It is the venture capital arm of New York Blood Center Enterprises, dedicated to improving patient outcomes through strategic investments.
Overview
What NYBC Ventures does
What NYBC Ventures is
NYBC Ventures is an early-stage investment fund based in Boston, Massachusetts, focusing on innovations in blood and cellular therapies. It is the venture capital arm of New York Blood Center Enterprises, dedicated to improving patient outcomes through strategic investments.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find NYBC Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
NYBC Ventures as a funder
Investment thesis
NYBC Ventures is dedicated to advancing innovation in blood and cell-based therapies and technologies to improve patient lives.
Focus narrative
NYBC Ventures invests in early to mid-stage innovations in blood and cellular therapies and related technologies. The organization supports therapeutics, devices, and other solutions that address challenges in hematology, transfusion medicine, cell therapy, and infectious disease.
Value beyond capital
Beyond capital, NYBC Ventures provides portfolio companies access to world-renowned researchers and their labs, cell manufacturing capacity, source materials, and deep domain expertise in blood and cell therapies.
Focus and fit
- Stages
- Seed · Series B
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 15
Portfolio context
Notable portfolio companies include STAR Therapeutics and Veralox Therapeutics, among others.
Common questions
What to know about NYBC Ventures
Upseed classifies NYBC Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.